Key result
Percutaneous treatment approaches for mitral regurgitation are generating considerable interest as less invasive alternatives to established surgical strategies.
Highlights the emerging interest in percutaneous approaches for treating mitral regurgitation as less invasive alternatives to traditional surgical strategies.
Emerging percutaneous mitral regurgitation options may expand choices; leaves open need for randomized trials vs surgery.
ercutaneous mitral valve therapy became a reality more than 25 years ago with the first description of balloon valvuloplasty for rheumatic mitral stenosis. 1 More recently, percutaneous closure of paravalvular leaks after surgical valve implantation has been shown to have a potential, but limited, role. 2-4 However, valvular mitral regurgitation (MR) remains largely the purview of surgery. Recently, the potential for less invasively replicating these successful surgical procedures without the need for thoracotomy or cardiopulmonary bypass has generated considerable interest. For the most part, these new approaches are modeled after established surgical strategies.
No takes yet. Share an insight, caveat, or question.
Masson et al. (2009) conducted a review in Mitral Regurgitation. Percutaneous treatment was evaluated. Percutaneous treatment approaches for mitral regurgitation are generating considerable interest as less invasive alternatives to established surgical strategies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: